Volume 19, Number 4—April 2013
CME ACTIVITY - Research
Risk Factors for Influenza among Health Care Workers during 2009 Pandemic, Toronto, Ontario, Canada
Table 5
Risk factor | OR (95% CI), adjusted† | OR (95% CI), multivariable‡ | |
---|---|---|---|
Age, y, per 10 y increase | 0.99 (0.63–1.56) | NA | |
Sex, F |
1.79 (0.23–14.04) |
NA |
|
Potential exposure conditions | |||
Receipt of A(H1N1)pdm09 vaccine§ | 0.49 (0.07–3.67)¶ | 0.40 (0.04–3.99) | |
Weekly specimens yielding influenza, %, per 5% increase | 1.56 (1.29–1.88) # | 1.43 (1.17–1.73) | |
Child <18 y in household | 3.33 (1.00–11.05) | NA | |
Contact with family member with ARI in prior week | 7.26 (2.15–24.54) | 7.86 (2.20–28.04) | |
Contact with co-worker with ARI in prior week | 1.40 (0.16–12.40) | NA | |
Cared for patient with ARI in prior week | 1.50 (0.44–5.14) | NA | |
Adherence to hand hygiene recommendations, per 10% increase | 0.84 (0.73–0.98) | 0.86 (0.74–0.99) | |
Adherence to facial protection recommendations, per 10% increase | 0.92 (0.79–1.07) | NA | |
No. AGMP performed or assisted during previous week, per 10 procedures increase** | 2.29 (1.26–4.17) | 1.95 (1.10–3.48) |
*Generalized estimating equation logistic regression analysis of constant and time-varying risk factors for influenza infection in 563 health care workers in acute care hospitals, Influenza Cohort Study, followed during June 2009–April 2010, OR, odds ratio; A(H1N1)pdm09: pandemic influenza A(H1N1) 2009 virus; NA, not applicable; ARI: acute respiratory illness; AGMP: aerosol-generating medical procedures.
†Adjusted for receipt of A(H1N1)pdm09 vaccine and weekly percentage of specimens yielding influenza.
‡Multivariable model including all variables with ORs listed below.
§Participants who had acquired A(H1N1)pdm09 <7 d after vaccination were considered unprotected.
¶Adjusted for weekly percentage of specimens yielding influenza only.
#Undadjusted.
**AGMP are defined as any one of the following: administration of nebulized therapy or humidified oxygen at >40%, use of bag-valve mask, manual ventilation, noninvasive ventilation, open airway suctioning, bronchoscopy or other upper airway endoscopy, tracheostomy, endotracheal intubation, cardiopulmonary resuscitation, oscillatory ventilation, any procedure performed that involves manipulation of open ventilator tubing in a mechanically ventilated patient, sputum induction or other deliberate induction of coughing; OR for being in the same room during AGMP (>1/week) 6.63 (95% CI 2.05–21.41); OR for participants performing AGMP (>1/week) 4.21 (1.12–15.76).
1Additional members of the Working Adult Influenza Cohort Study Group are listed at the end of this article.
1Additional members of the Working Adult Influenza Cohort Study Group are listed at the end of this article.